These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells. Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680 [TBL] [Abstract][Full Text] [Related]
3. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype. Milovanovic M; Volarevic V; Ljujic B; Radosavljevic G; Jovanovic I; Arsenijevic N; Lukic ML PLoS One; 2012; 7(9):e45225. PubMed ID: 23028861 [TBL] [Abstract][Full Text] [Related]
4. IL-33/ST2 axis in inflammation and immunopathology. Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053 [TBL] [Abstract][Full Text] [Related]
5. IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis. Babic ZM; Zunic FZ; Pantic JM; Radosavljevic GD; Jovanovic IP; Arsenijevic NN; Lukic ML J Biomed Sci; 2018 Jul; 25(1):56. PubMed ID: 30001716 [TBL] [Abstract][Full Text] [Related]
6. CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses. Vinay DS; Choi BK; Bae JS; Kim WY; Gebhardt BM; Kwon BS J Immunol; 2004 Sep; 173(6):4218-29. PubMed ID: 15356173 [TBL] [Abstract][Full Text] [Related]
7. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice. Zhao J; Zhang H; Liu SB; Han P; Hu S; Li Q; Wang ZF; Mao-Ying QL; Chen HM; Jiang JW; Wu GC; Mi WL; Wang YQ Neuroscience; 2013 Dec; 253():172-82. PubMed ID: 23988433 [TBL] [Abstract][Full Text] [Related]
8. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. Ma HL; Whitters MJ; Konz RF; Senices M; Young DA; Grusby MJ; Collins M; Dunussi-Joannopoulos K J Immunol; 2003 Jul; 171(2):608-15. PubMed ID: 12847225 [TBL] [Abstract][Full Text] [Related]
9. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Kasaian MT; Whitters MJ; Carter LL; Lowe LD; Jussif JM; Deng B; Johnson KA; Witek JS; Senices M; Konz RF; Wurster AL; Donaldson DD; Collins M; Young DA; Grusby MJ Immunity; 2002 Apr; 16(4):559-69. PubMed ID: 11970879 [TBL] [Abstract][Full Text] [Related]
10. Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii. Ferreira LS; Portuondo DL; Polesi MC; Carlos IZ Immunology; 2018 Dec; 155(4):467-476. PubMed ID: 30030839 [TBL] [Abstract][Full Text] [Related]
11. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani. Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639 [TBL] [Abstract][Full Text] [Related]
12. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. Kim HY; Chang YJ; Subramanian S; Lee HH; Albacker LA; Matangkasombut P; Savage PB; McKenzie AN; Smith DE; Rottman JB; DeKruyff RH; Umetsu DT J Allergy Clin Immunol; 2012 Jan; 129(1):216-27.e1-6. PubMed ID: 22119406 [TBL] [Abstract][Full Text] [Related]
13. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection. Zeng S; Wu J; Liu J; Qi F; Liu B Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734 [TBL] [Abstract][Full Text] [Related]
14. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Smithgall MD; Comeau MR; Yoon BR; Kaufman D; Armitage R; Smith DE Int Immunol; 2008 Aug; 20(8):1019-30. PubMed ID: 18550585 [TBL] [Abstract][Full Text] [Related]
15. Dual blockage of PD-L/PD-1 and IL33/ST2 axes slows tumor growth and improves antitumor immunity by boosting NK cells. Jovanovic MZ; Geller DA; Gajovic NM; Jurisevic MM; Arsenijevic NN; Jovanovic MM; Supic GM; Vojvodic DV; Jovanovic IP Life Sci; 2022 Jan; 289():120214. PubMed ID: 34890591 [TBL] [Abstract][Full Text] [Related]
16. IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice. Di Carlo E; Comes A; Orengo AM; Rosso O; Meazza R; Musiani P; Colombo MP; Ferrini S J Immunol; 2004 Feb; 172(3):1540-7. PubMed ID: 14734732 [TBL] [Abstract][Full Text] [Related]
17. In vivo acute depletion of CD8(+) T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells. Salem ML; Hossain MS Int J Immunopharmacol; 2000 Sep; 22(9):707-18. PubMed ID: 10884591 [TBL] [Abstract][Full Text] [Related]
18. ST2 deletion increases inflammatory bone destruction in experimentally induced periapical lesions in mice. Velickovic M; Pejnovic N; Mitrovic S; Radosavljevic G; Jovanovic I; Kanjevac T; Jovicic N; Lukic A J Endod; 2015 Mar; 41(3):369-75. PubMed ID: 25595464 [TBL] [Abstract][Full Text] [Related]